Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
175 | Drug Topics | journal | 0.100 Q4 | 8 | 116 | 484 | 46 | 5 | 57 | 0.01 | 0.40 | 61.29 | |
174 | Pharmacy Times | trade journal | 0.100 Q4 | 8 | 0 | 444 | 0 | 2 | 299 | 0.00 | 0.00 | 0.00 | |
173 | Pharmaceutical Technology Europe | journal | 0.101 Q4 | 19 | 131 | 170 | 627 | 1 | 135 | 0.01 | 4.79 | 46.67 | |
172 | Pharmaceutical Outsourcing | journal | 0.103 Q4 | 7 | 0 | 15 | 0 | 0 | 12 | 0.00 | 0.00 | 0.00 | |
171 | BioPharm International | trade journal | 0.104 Q4 | 32 | 130 | 252 | 574 | 30 | 98 | 0.14 | 4.42 | 50.00 | |
170 | Journal of Experimental Therapeutics and Oncology | journal | 0.107 Q4 | 40 | 0 | 17 | 0 | 2 | 16 | 0.20 | 0.00 | 0.00 | |
169 | National Toxicology Program technical report series | journal | 0.108 | 22 | 0 | 6 | 0 | 1 | 6 | 0.20 | 0.00 | 0.00 | |
168 | Food and Drug Law Journal | journal | 0.110 Q4 | 23 | 11 | 3 | 1198 | 0 | 3 | 0.00 | 108.91 | 46.67 | |
167 | Journal of Caffeine and Adenosine Research | journal | 0.111 Q4 | 1 | 0 | 8 | 0 | 3 | 5 | 0.38 | 0.00 | 0.00 | |
166 | Drug Development and Delivery | trade journal | 0.115 Q4 | 12 | 60 | 201 | 430 | 26 | 109 | 0.14 | 7.17 | 26.32 | |
165 | International Journal of Pharmaceutical Compounding | journal | 0.118 Q4 | 13 | 62 | 212 | 0 | 64 | 198 | 0.15 | 0.00 | 43.97 | |
164 | WikiJournal of Medicine | journal | 0.119 Q4 | 4 | 4 | 18 | 690 | 11 | 18 | 0.40 | 172.50 | 20.00 | |
163 | Pharmaceutical Technology | journal | 0.121 Q4 | 42 | 78 | 522 | 319 | 47 | 224 | 0.11 | 4.09 | 50.00 | |
162 | U.S. Pharmacist | trade journal | 0.124 Q4 | 12 | 125 | 375 | 716 | 66 | 259 | 0.17 | 5.73 | 62.20 | |
161 | Adverse Drug Reaction Bulletin | journal | 0.126 Q4 | 8 | 6 | 18 | 173 | 7 | 18 | 0.42 | 28.83 | 50.00 | |
160 | American Pharmaceutical Review | journal | 0.127 Q4 | 26 | 0 | 86 | 0 | 16 | 77 | 0.14 | 0.00 | 0.00 | |
159 | International Nano Letters | journal | 0.131 Q4 | 26 | 31 | 91 | 2456 | 613 | 91 | 4.46 | 79.23 | 32.22 | |
158 | Molecular and Cellular Pharmacology | journal | 0.131 Q4 | 28 | 2 | 3 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
157 | NTP Immunotoxicity Technical Report Series | book series | 0.131 Q4 | 0 | 0 | 3 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
156 | PDA Journal of Pharmaceutical Science and Technology | journal | 0.150 Q3 | 43 | 14 | 152 | 0 | 104 | 139 | 0.62 | 0.00 | 25.93 | |
155 | Dissolution Technologies | journal | 0.185 Q3 | 36 | 24 | 63 | 802 | 44 | 59 | 0.71 | 33.42 | 39.45 | |
154 | Journal of Excipients and Food Chemicals | journal | 0.190 Q3 | 17 | 11 | 30 | 285 | 17 | 17 | 0.42 | 25.91 | 51.85 | |
153 | Pharmaceutical Chemistry Journal | journal | 0.192 Q4 | 39 | 257 | 612 | 7879 | 547 | 610 | 0.78 | 30.66 | 49.12 | |
152 | Medical Letter on Drugs and Therapeutics | journal | 0.211 Q4 | 22 | 132 | 306 | 905 | 184 | 224 | 0.71 | 6.86 | 0.00 | |
151 | Journal of Pharmacy Technology | journal | 0.237 Q3 | 16 | 51 | 117 | 1218 | 99 | 103 | 0.79 | 23.88 | 40.44 | |
150 | Hospital Pharmacy | journal | 0.243 Q3 | 28 | 121 | 249 | 2436 | 236 | 217 | 0.84 | 20.13 | 48.11 | |
149 | Journal of Liquid Chromatography and Related Technologies | journal | 0.247 Q3 | 57 | 28 | 248 | 1404 | 338 | 248 | 1.25 | 50.14 | 44.63 | |
148 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.255 Q3 | 34 | 27 | 93 | 938 | 143 | 93 | 1.70 | 34.74 | 36.36 | |
147 | International Journal of Medicinal Mushrooms | journal | 0.274 Q3 | 41 | 84 | 312 | 3708 | 479 | 310 | 1.37 | 44.14 | 44.92 | |
146 | Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.] | journal | 0.287 Q4 | 31 | 0 | 31 | 0 | 42 | 31 | 0.90 | 0.00 | 0.00 | |
145 | Natural Product Communications | journal | 0.288 Q3 | 63 | 294 | 887 | 12870 | 1605 | 866 | 1.90 | 43.78 | 41.21 | |
144 | Clinical Neuropharmacology | journal | 0.293 Q3 | 85 | 43 | 172 | 1081 | 201 | 158 | 0.98 | 25.14 | 35.29 | |
143 | Applied In Vitro Toxicology | journal | 0.315 Q4 | 15 | 15 | 52 | 563 | 71 | 42 | 1.36 | 37.53 | 43.75 | |
142 | Journal of Pharmaceutical Innovation | journal | 0.357 Q2 | 35 | 124 | 156 | 5545 | 372 | 147 | 2.41 | 44.72 | 40.08 | |
141 | Assay and Drug Development Technologies | journal | 0.358 Q3 | 65 | 34 | 128 | 1424 | 265 | 120 | 1.78 | 41.88 | 39.47 | |
140 | Journal of AOAC International | journal | 0.358 Q3 | 100 | 169 | 617 | 3177 | 1237 | 594 | 1.61 | 18.80 | 45.20 | |
139 | Canadian Pharmacists Journal | journal | 0.362 Q2 | 30 | 54 | 198 | 1132 | 175 | 114 | 0.79 | 20.96 | 59.38 | |
138 | Medicinal Chemistry Research | journal | 0.377 Q2 | 59 | 166 | 536 | 7566 | 1429 | 532 | 2.61 | 45.58 | 43.30 | |
137 | ACS Bio and Med Chem Au | journal | 0.379 Q2 | 11 | 55 | 7 | 3788 | 14 | 6 | 2.00 | 68.87 | 41.70 | |
136 | Chirality | journal | 0.382 Q3 | 83 | 119 | 303 | 6056 | 626 | 301 | 2.11 | 50.89 | 37.66 | |
135 | Therapeutic Innovation and Regulatory Science | journal | 0.387 Q2 | 51 | 99 | 501 | 3104 | 606 | 443 | 1.42 | 31.35 | 49.77 | |
134 | JACCP Journal of the American College of Clinical Pharmacy | journal | 0.394 Q2 | 19 | 154 | 443 | 5156 | 593 | 368 | 1.41 | 33.48 | 62.29 | |
133 | Mental Health Clinician | journal | 0.403 Q2 | 23 | 28 | 109 | 770 | 161 | 109 | 0.95 | 27.50 | 64.42 | |
132 | Archives of Environmental and Occupational Health | journal | 0.409 Q3 | 68 | 86 | 168 | 3264 | 326 | 161 | 1.86 | 37.95 | 40.41 | |
131 | Journal of Biomedical Nanotechnology | journal | 0.409 Q2 | 93 | 116 | 543 | 0 | 1389 | 543 | 2.20 | 0.00 | 41.11 | |
130 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.420 Q2 | 82 | 17 | 49 | 2440 | 173 | 49 | 3.08 | 143.53 | 32.39 | |
129 | Journal of Environmental Pathology, Toxicology and Oncology | journal | 0.429 Q3 | 50 | 27 | 92 | 1006 | 227 | 92 | 2.45 | 37.26 | 44.44 | |
128 | International Journal of Toxicology | journal | 0.432 Q3 | 71 | 52 | 173 | 2159 | 355 | 155 | 1.99 | 41.52 | 45.42 | |
127 | Current Cardiovascular Risk Reports | journal | 0.433 Q3 | 34 | 25 | 85 | 1868 | 101 | 85 | 1.38 | 74.72 | 57.50 | |
126 | Current Therapeutic Research | journal | 0.445 Q3 | 46 | 32 | 109 | 1105 | 220 | 103 | 1.77 | 34.53 | 41.72 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®